BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 20394623)

  • 1. Partial response to bevacizumab of an extensive cutaneous angiosarcoma of the face.
    Rosen A; Thimon S; Ternant D; Machet MC; Paintaud G; Machet L
    Br J Dermatol; 2010 Jul; 163(1):225-7. PubMed ID: 20394623
    [No Abstract]   [Full Text] [Related]  

  • 2. Preoperative radiotherapy and bevacizumab for angiosarcoma of the head and neck: two case studies.
    Koontz BF; Miles EF; Rubio MA; Madden JF; Fisher SR; Scher RL; Brizel DM
    Head Neck; 2008 Feb; 30(2):262-6. PubMed ID: 17685450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dramatic improvement of inoperable angiosarcoma with combination paclitaxel and bevacizumab chemotherapy.
    Fuller CK; Charlson JA; Dankle SK; Russell TJ
    J Am Acad Dermatol; 2010 Oct; 63(4):e83-4. PubMed ID: 20846560
    [No Abstract]   [Full Text] [Related]  

  • 4. Unresectable angiosarcoma treated with bevacizumab and paclitaxel.
    Nespereira-Jato MV; Peña-Panabad C; Quindós-Varela M; García-Silva J
    Actas Dermosifiliogr; 2014 Jun; 105(5):520-2. PubMed ID: 24144236
    [No Abstract]   [Full Text] [Related]  

  • 5. Malignant transformation of infantile hemangioma to angiosarcoma: response to chemotherapy with bevacizumab.
    Jeng MR; Fuh B; Blatt J; Gupta A; Merrow AC; Hammill A; Adams D
    Pediatr Blood Cancer; 2014 Nov; 61(11):2115-7. PubMed ID: 24740626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravitreal bevacizumab for vitreous haemorrhage.
    Jonas JB; Libondi T; von Baltz S; Vossmerbaeumer U
    Acta Ophthalmol; 2008 Aug; 86(5):585-6. PubMed ID: 18081904
    [No Abstract]   [Full Text] [Related]  

  • 7. Paclitaxel in the treatment of patients with angiosarcoma of the scalp or face.
    Fata F; O'Reilly E; Ilson D; Pfister D; Leffel D; Kelsen DP; Schwartz GK; Casper ES
    Cancer; 1999 Nov; 86(10):2034-7. PubMed ID: 10570428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early detection of cutaneous angiosarcoma of the face and scalp and treatment with placitaxel.
    Pestoni C; Paredes-Suarez C; Peteiro C; Toribio J
    J Eur Acad Dermatol Venereol; 2005 May; 19(3):357-9. PubMed ID: 15857466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bevacizumab-based therapy for advanced small bowel adenocarcinoma.
    Tsang H; Yau T; Khong PL; Epstein RJ
    Gut; 2008 Nov; 57(11):1631-2. PubMed ID: 18941013
    [No Abstract]   [Full Text] [Related]  

  • 10. Bevacizumab for recurrent malignant gliomas: efficacy, toxicity, and patterns of recurrence.
    Chamberlain MC
    Neurology; 2009 Feb; 72(8):772-3; author reply 773-4. PubMed ID: 19237713
    [No Abstract]   [Full Text] [Related]  

  • 11. Angiosarcoma of the scalp and face: failure of an interferon alpha treatment.
    Guillot B; Raison-Peyron N; Acevedo M; Meunier L; Dandurand M; Meynadier J
    Eur J Dermatol; 2000 Jun; 10(4):300-2. PubMed ID: 10846259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of a vasoproliferative tumour with intravitreal bevacizumab (Avastin).
    Kenawy N; Groenwald C; Damato B
    Eye (Lond); 2007 Jun; 21(6):893-4. PubMed ID: 17347676
    [No Abstract]   [Full Text] [Related]  

  • 13. Combined treatment of a juxtapapillary retinal capillary haemangioma with intravitreal bevacizumab and photodynamic therapy.
    Ziemssen F; Voelker M; Inhoffen W; Bartz-Schmidt KU; Gelisken F
    Eye (Lond); 2007 Aug; 21(8):1125-6. PubMed ID: 17545966
    [No Abstract]   [Full Text] [Related]  

  • 14. Intravitreal bevacizumab for treatment of choroidal neovascularization secondary to angioid streaks.
    Apte RS
    Eye (Lond); 2008 May; 22(5):734-5. PubMed ID: 18344971
    [No Abstract]   [Full Text] [Related]  

  • 15. Bevacizumab for the treatment of epithelial ovarian cancer: will this be its finest hour?
    Kaye SB
    J Clin Oncol; 2007 Nov; 25(33):5150-2. PubMed ID: 18024860
    [No Abstract]   [Full Text] [Related]  

  • 16. Neoadjuvant bevacizumab in a granulosa cell tumor of the ovary: a case report.
    Barrena Medel NI; Herzog TJ; Wright JD; Lewin SN
    Anticancer Res; 2010 Nov; 30(11):4767-8. PubMed ID: 21115938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Choroidal neovascular membrane complicating traumatic choroidal rupture managed by intravitreal bevacizumab.
    Yadav NK; Bharghav M; Vasudha K; Shetty KB
    Eye (Lond); 2009 Sep; 23(9):1872-3. PubMed ID: 19079144
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of intravitreal bevacizumab treatment on choroidal metastasis of colon adenocarcinoma--case report.
    Lin CJ; Li KH; Hwang JF; Chen SN
    Eye (Lond); 2010 Jun; 24(6):1102-3. PubMed ID: 19893587
    [No Abstract]   [Full Text] [Related]  

  • 19. [Avastin treatment in intraocular tumors].
    Macovei L; Carstocea B; Buliga S; Cerbulescu B
    Oftalmologia; 2010; 54(2):66-70. PubMed ID: 20827913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Digestive neoplasms and bevacizumab].
    Bennouna J
    J Chir (Paris); 2008 Jan; 145 Spec No 1():1S16-20. PubMed ID: 18575432
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.